CPhI North America is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.
Eugene Choi, Ph.D., defines and leads the strategic direction of the Medicines for All Institute, including defining organizational priorities, overseeing programs, and developing strategic partnerships. Previously, Choi was the chief engineer at the Defense Advanced Research Projects Agency for the Pharmacy on Demand and Biologically-derived Medicines on Demand programs. These initiatives developed flexible pharmaceuticals and biologics manufacturing platforms capable of producing multiple drugs. Choi has also designed and managed multiple technology development projects for Strategic Analysis, Inc., enabling capabilities for the Department of Defense. He also served as a researcher in materials science and biomedical engineering at the National Academies and the National Institutes of Health. He holds a B.S. in biology from Indiana University and a Ph.D. in polymer science from the University of Akron.